Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 3
Submit an article Journal homepage
156
Views
57
CrossRef citations to date
0
Altmetric
Research Article

Vascular Events Associated with Alpha Interferon Therapy

H. Al-Zahrani Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health network, 610 University Avenue, Toronto Ont., Canada, M5G 2M9
,
V. Gupta Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health network, 610 University Avenue, Toronto Ont., Canada, M5G 2M9
,
M.D. Minden Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health network, 610 University Avenue, Toronto Ont., Canada, M5G 2M9
,
H.A. Messner Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health network, 610 University Avenue, Toronto Ont., Canada, M5G 2M9
&
J.H. Lipton Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health network, 610 University Avenue, Toronto Ont., Canada, M5G 2M9
Pages 471-475 | Published online: 01 Jul 2009

  • Talpaz, M., Kantarjian, H.M., O'Brien, S. and Kurzrock, R. (1997) "The M.D. Anderson Cancer Center experience with interferonalpha therapy in chronic myelogenous leukaemia", Baillieres Clin. Haematol. 10, 291-305.
  • Goldman, J.M. (1997) "Chronic myeloid leukemia", Curr. Opin. Hematol. 4, 277-285.
  • Guilhot, E, Chastang, C., Michallet, M, Guerci, A., Harousseau, I.L., Maloisel, F., Bouabdallah, R., Guyotat, D., Cheron, N., Nicolini, F., Abgrall, J.F. and Tanzer, J. (1997) "Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia", N. Engl. J. Med. 337, 223-229, French Chronic Myeloid Leukemia Study Group.
  • Jones, R.J. (1997) "Biology and treatment of chronic myeloid leukemia", Curr. Opin. Oncol. 9, 3-7.
  • Vial, T. and Descotes, J. (1994) "Clinical toxicity of the interferons", Drug Saf 10, 115-150.
  • Sonnenblick, M. and Rosin, A. (1991) "Cardiotoxicity of interferon. A review of 44 cases", Chest 99, 557-561.
  • Best, P.J., Daoud, M.S., Pittelkow, M.R. and Petitt, R.M. (1998) "Hydroxyurea-induced leg ulceration in 14 patients", Ann. Intern. Med. 128, 29-32.
  • Kawano, T., Shigehira, M., Uto, H., Nakama, T., Kato, J., Hayashi, K., Maruyama, T., Kuribayashi, T., Chuman, T., Futami, T. and Tsubouchi, H. (1996) "Retinal complications during interferon therapy for chronic hepatitis C', Am. J. Gastroenterol. 91,309-313.
  • Soushi, S., Kbbayashi, E, Obazawa, H., Kigasawa, K., Shiraishi, K., Itakura, M. and Matsuzaki, S. (1996) "Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis", Nippon Ganka Gakkai Zasshi 100, 69-76.
  • Hayasaka, S., Fujii, M., Yamamoto, Y., Noda, S., Kurome, H. and Sasaki, M. (1995) "Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa", Br. J. Ophthalmol. 79, 150-152.
  • Sangster, G., Kaye, S.B., Caiman, K.C. and Toy, J.L. (1983) "Cutaneous vasculitis associated with interferon", Eur. J. Cancer Clin. Oncol. 19, 1647-1649.
  • Bachmeyer, C., Farge, D., Gluckman, E., Miclea, J.M. and Aractingi, S. (1996) "Raynaud's phenomenon and digital necrosis induced by interferon-alpha", Br. J. Dermatol. 135, 481-483.
  • Liozon, E., Delaire, L., Lacroix, P., Labrousse, E, Ly, K., Fauchais, A.L., Loustaud-Ratti, V, Vidai, J., Liozon, F. and Vidai, E. (1997) "Raynaud syndrome complicated by digital gangrene during treatment with interferon-alpha", Rev. Med. Intern. 18, 316-319.
  • Shinohara, K. (1995) "More on interferon-induced cutaneous necrosis", N. Engl. J. Med. 333, 1222, discussion 1223-4.
  • Berard, E, Canillot, S., Balme, B. and Perrot, H. (1995) "Local cutaneous necrosis after injection of interferon beta", Ann. Dermatol. Venereol. 122, 105-107.
  • Webster, G.F., Knobler, R.L., Lublin, F.D., Kramer, EM. and Hochman, L.R. (1996) "Cutaneous ulcérations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis", J. Am. Acad. Dermatol. 34, 365-367.
  • Cnudde, E, Gharakhanian, S., Luboinski, J., Dry, I. and Rozenbaum, W. (1991) "Cutaneous local necrosis following interferon injections", Int. J. Dermatol. 30, 147.
  • Leavitt, T.J., Merigan, T.C. and Freeman, J.M. (1971) "Hemolytic-uremic-like syndrome following polycarboxylate interferon induction. Treatment of Dawson's inclusion-body encephalitis", Am. J. Da. Child. 121, 43-47.
  • Kobayashi, H., Utsunomiya, Y, Miyazaki, Y, Tokutome, G., Kawamura, T., Hashimoto, T., Sakai, T., Takahashi, S., Tojyo, A. and Asano, S. (1997) "Case of chronic myelogenous leukemia with hemolytic-uremic-syndrome like kidney during long-term interferon-alpha therapy", Nippon Naika Gakkai Zasshi 86,1259-1261.
  • Honda, K., Ando, A., Endo, M., Shimizu, K., Higashihara, M., Nitta, K. and Nihei, H. (1997) "Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia", Am. J. Kidney Dis. 30, 123-130.
  • Lipton, J.H. and Minden, M. (1995) "CML may not be part of HUS", Am. J. Hematol. 49, 100-101.
  • Stratta, P., Canavese, C., Dogliani, M., Thea, A., Degani, G., Mairone, L. and Vercellone, A. (1993) "Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for hairy cell leukemia", Renal Fail. 15, 559-561.
  • Shiomi, S., Kuroki, T., Yokogawa, T., Takeda, T, Nishiguchi, S., Nakajima, S., Tanaka, T., Okamura, T. and Ochi, H. (1997) "Changes in results of Gallium-67-citrate scanning after interferon therapy for chronic hepatitis C", J. Nucl Med. 38, 216-219.
  • Kramers, C., de Mulder, P.H., Earth, I.D. and Wagener, DJ. (1993) "Acute right ventricular heart failure in a patient with renal cell carcinoma after interferon therapy", Neth. J. Med. 42, 65-68.
  • Hooks, J.J., Jordan, G.W., Cupps, T., Moutsopoulos, H.M., Fauci, A.S. and Notkins, A.L. (1982) "Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis", Arthritis Rheum. 25, 396-400.
  • Creutzig, A., Freund, M., Caspary, L. and Alexander, K. (1996) "Microangiopathy in patients with chronic myelogenous leukemia treated with interferon", Microvasc. Res. 52, 288-292.
  • Dvorak, H.F. and Grosser, I. (1989) "Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice", J. Natl Cancer Inst. 81, 497-502.
  • Islam, M., Frye, R.F., Richards, T.J., Sbeitan, L, Donnelly, S.S., Glue, P., Agarwala, S.S. and Kirkwood, J.M. (2002) "Differential effect of IFNalpha-2b on the cytochrome P450 enzyme system: a potential basis of IFN toxicity and its modulation by other drugs", Clin. Cancer Res. 8, 2480-2487.
  • Creutzig, A., Caspary, L. and Freund, M. (1996) "The Raynaud phenomenon and interferon therapy", Ann. Intern. Med. 125, 423.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.